IBDEI0ZU ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16521,1,3,0)
 ;;=3^Vestibular Function Disorder,Bilateral
 ;;^UTILITY(U,$J,358.3,16521,1,4,0)
 ;;=4^H81.93
 ;;^UTILITY(U,$J,358.3,16521,2)
 ;;=^5006889
 ;;^UTILITY(U,$J,358.3,16522,0)
 ;;=R63.0^^88^850^1
 ;;^UTILITY(U,$J,358.3,16522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16522,1,3,0)
 ;;=3^Anorexia
 ;;^UTILITY(U,$J,358.3,16522,1,4,0)
 ;;=4^R63.0
 ;;^UTILITY(U,$J,358.3,16522,2)
 ;;=^7939
 ;;^UTILITY(U,$J,358.3,16523,0)
 ;;=R64.^^88^850^2
 ;;^UTILITY(U,$J,358.3,16523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16523,1,3,0)
 ;;=3^Cachexia
 ;;^UTILITY(U,$J,358.3,16523,1,4,0)
 ;;=4^R64.
 ;;^UTILITY(U,$J,358.3,16523,2)
 ;;=^17920
 ;;^UTILITY(U,$J,358.3,16524,0)
 ;;=E86.0^^88^850^4
 ;;^UTILITY(U,$J,358.3,16524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16524,1,3,0)
 ;;=3^Dehydration
 ;;^UTILITY(U,$J,358.3,16524,1,4,0)
 ;;=4^E86.0
 ;;^UTILITY(U,$J,358.3,16524,2)
 ;;=^332743
 ;;^UTILITY(U,$J,358.3,16525,0)
 ;;=Z86.31^^88^850^75
 ;;^UTILITY(U,$J,358.3,16525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16525,1,3,0)
 ;;=3^Personal Hx of Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,16525,1,4,0)
 ;;=4^Z86.31
 ;;^UTILITY(U,$J,358.3,16525,2)
 ;;=^5063467
 ;;^UTILITY(U,$J,358.3,16526,0)
 ;;=E10.8^^88^850^5
 ;;^UTILITY(U,$J,358.3,16526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16526,1,3,0)
 ;;=3^Diabetes Type 1 w/ Unspec Complications
 ;;^UTILITY(U,$J,358.3,16526,1,4,0)
 ;;=4^E10.8
 ;;^UTILITY(U,$J,358.3,16526,2)
 ;;=^5002625
 ;;^UTILITY(U,$J,358.3,16527,0)
 ;;=E10.9^^88^850^6
 ;;^UTILITY(U,$J,358.3,16527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16527,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,16527,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,16527,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,16528,0)
 ;;=E11.40^^88^850^15
 ;;^UTILITY(U,$J,358.3,16528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16528,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,16528,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,16528,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,16529,0)
 ;;=E11.620^^88^850^11
 ;;^UTILITY(U,$J,358.3,16529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16529,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Dermatitis
 ;;^UTILITY(U,$J,358.3,16529,1,4,0)
 ;;=4^E11.620
 ;;^UTILITY(U,$J,358.3,16529,2)
 ;;=^5002655
 ;;^UTILITY(U,$J,358.3,16530,0)
 ;;=E11.610^^88^850^14
 ;;^UTILITY(U,$J,358.3,16530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16530,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,16530,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,16530,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,16531,0)
 ;;=E11.52^^88^850^17
 ;;^UTILITY(U,$J,358.3,16531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16531,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Periph Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,16531,1,4,0)
 ;;=4^E11.52
 ;;^UTILITY(U,$J,358.3,16531,2)
 ;;=^5002651
 ;;^UTILITY(U,$J,358.3,16532,0)
 ;;=E11.51^^88^850^18
 ;;^UTILITY(U,$J,358.3,16532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16532,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Periph Angiopathy w/o Gangrene
 ;;^UTILITY(U,$J,358.3,16532,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,16532,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,16533,0)
 ;;=E11.621^^88^850^21
 ;;^UTILITY(U,$J,358.3,16533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16533,1,3,0)
 ;;=3^Diabetes Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,16533,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,16533,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,16534,0)
 ;;=E11.44^^88^850^8
